Kaul H - Search Results

1

Uremia-associated immune defect: the IL-10-CRP axis.

Girndt M, Ulrich C, Kaul H, Sester U, Sester M, Köhler H. Girndt M, et al. Among authors: kaul h. Kidney Int Suppl. 2003 May;(84):S76-9. doi: 10.1046/j.1523-1755.63.s84.14.x. Kidney Int Suppl. 2003. PMID: 12694315 Free article. Review.

2

Anti-inflammatory interleukin-10 genotype protects dialysis patients from cardiovascular events.

Girndt M, Kaul H, Sester U, Ulrich C, Sester M, Georg T, Köhler H. Girndt M, et al. Among authors: kaul h. Kidney Int. 2002 Sep;62(3):949-55. doi: 10.1046/j.1523-1755.2002.00504.x. Kidney Int. 2002. PMID: 12164877 Free article.

3

Production of proinflammatory and regulatory monokines in hemodialysis patients shown at a single-cell level.

Girndt M, Sester U, Kaul H, Köhler H. Girndt M, et al. Among authors: kaul h. J Am Soc Nephrol. 1998 Sep;9(9):1689-96. doi: 10.1681/ASN.V991689. J Am Soc Nephrol. 1998. PMID: 9727378 Clinical Trial.

4

Prospective crossover trial of the influence of vitamin E-coated dialyzer membranes on T-cell activation and cytokine induction.

Girndt M, Lengler S, Kaul H, Sester U, Sester M, Köhler H. Girndt M, et al. Among authors: kaul h. Am J Kidney Dis. 2000 Jan;35(1):95-104. doi: 10.1016/S0272-6386(00)70307-6. Am J Kidney Dis. 2000. PMID: 10620550 Clinical Trial.

5

Initiation of hemodialysis treatment leads to improvement of T-cell activation in patients with end-stage renal disease.

Kaul H, Girndt M, Sester U, Sester M, Köhler H. Kaul H, et al. Am J Kidney Dis. 2000 Apr;35(4):611-6. doi: 10.1016/s0272-6386(00)70006-0. Am J Kidney Dis. 2000. PMID: 10739780 Clinical Trial.

6

Molecular aspects of T- and B-cell function in uremia.

Girndt M, Sester M, Sester U, Kaul H, Köhler H. Girndt M, et al. Among authors: kaul h. Kidney Int Suppl. 2001 Feb;78:S206-11. doi: 10.1046/j.1523-1755.2001.59780206.x. Kidney Int Suppl. 2001. PMID: 11169012 Free article. Review.

7

Defective expression of B7-2 (CD86) on monocytes of dialysis patients correlates to the uremia-associated immune defect.

Girndt M, Sester M, Sester U, Kaul H, Köhler H. Girndt M, et al. Among authors: kaul h. Kidney Int. 2001 Apr;59(4):1382-9. doi: 10.1046/j.1523-1755.2001.0590041382.x. Kidney Int. 2001. PMID: 11260399 Free article.

8

The interleukin-10 promoter genotype determines clinical immune function in hemodialysis patients.

Girndt M, Sester U, Sester M, Deman E, Ulrich C, Kaul H, Köhler H. Girndt M, et al. Among authors: kaul h. Kidney Int. 2001 Dec;60(6):2385-91. doi: 10.1046/j.1523-1755.2001.00062.x. Kidney Int. 2001. PMID: 11737614 Free article.

9

Influence of cytokine gene polymorphisms on erythropoetin dose requirements in chronic haemodialysis patients.

Girndt M, Stenvinkel P, Ulrich C, Axelsson J, Nordfors L, Barany P, Carrero JJ, Heine GH, Kaul H, Köhler H. Girndt M, et al. Among authors: kaul h. Nephrol Dial Transplant. 2007 Dec;22(12):3586-92. doi: 10.1093/ndt/gfm244. Epub 2007 Sep 17. Nephrol Dial Transplant. 2007. PMID: 17875573

10

T-cell activation follows Th1 rather than Th2 pattern in haemodialysis patients.

Sester U, Sester M, Hauk M, Kaul H, Köhler H, Girndt M. Sester U, et al. Among authors: kaul h. Nephrol Dial Transplant. 2000 Aug;15(8):1217-23. doi: 10.1093/ndt/15.8.1217. Nephrol Dial Transplant. 2000. PMID: 10910448

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

170 results

Search Page

Filters